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Authoring scientific papers: a perspective from the
trenches
Adriano Aguzzi
Editor in chief, Swiss Medical Weekly / Institute of Neuropathology, University Hospital of Zurich, Switzerland
It has taken a while, but the Swiss Academies of Arts and
Sciences (SAAS) have come out with a valuable booklet
on authorships of scientific manuscripts [1]. This recom-
mendations, published now also as a special article in the
Swiss Medical Weekly [2], aspire to serve as a practical
guide for principal investigators confronted with the task of
assigning authorships to the individuals contributing to sci-
entific manuscripts. This undertaking is very valuable and
timely – particularly when considering that disputes over
authorships are extremely common. Such disputes are of-
ten very disruptive and can escalate to extreme levels, lead-
ing to lifelong feuds and animosities. Indeed, the task of
assigning authorships is generally not associated with pos-
itive feelings.
To some extent this is understandable and, perhaps, un-
avoidable, as authorships are de facto the currency of aca-
demia. Funding agencies rely primarily on authorships to
rank their applicants and for young scientists the prospect
of an independent good job at any prestigious academic
institution and, increasingly, in private companies, is cru-
cially dependent on authorships. The importance of author-
ships is not limited to senior scientists, but extends to the
appropriation of fellowships by PhD students and postdoc-
toral fellows. For the most prestigious fellowships, such
as the European Molecular Biology Organization (EMBO)
long-term fellowships and those of the Human Frontier
Science Foundation, applicants are disqualified upfront if
they do not present at least one first-author publication.
Hence the proper assignment of authorships is an ex-
tremely important exercise with huge reverberations on the
livelihood and the professional prospects of those involved.
In the following sections, I will comment on the guidelines
laid out by the SAAS in the light of my 25 years of ex-
perience as a laboratory scientist. Admittedly, in the course
of publishing a few hundred scientific papers, I have made
every conceivable mistake that could be made in this area
(however, I hasten to add that I strove to make each mistake
only once) – a fact that may perhaps endow me with the
justification to elaborate these matters in some detail.
Give credit where credit is due
SAAS should be commended for stating “Failure to give
due credit in the byline to junior scientists for their re-
search or writing efforts contravenes the rules of scientific
integrity. Anyone who fulfils the criteria for authorship
must be listed.” This principle may seem self-evident, but
reality shows otherwise. The most egregious infractions
are rarely committed by laboratory directors (who, in the
overwhelming majority of cases, behave honourably), but
rather by journal editors and publishers. These circum-
stances are particularly deplorable because journals often
pose as the wardens of scientific ethics – particularly when
it comes to blaming authors for whatever might have gone
wrong. I vividly remember a highly emotional discussion
with the editor of The Lancet, when Nicolas Kopp and I
reported the first case of variant Creutzfeldt-Jakob disease
occurring outside the United Kingdom. The editor of The
Lancet wanted to publish our paper [3], yet categorically
refused to list more than five authors – although additional
scientists did indeed qualify as authors according to the
SAAS’s criteria. What ensued was an emotionally charged
discussion, in which my coworkers threatened to resign and
I, conversely, threatened to withdraw the article in ques-
tion. The Lancet eventually caved in – but this does not re-
deem them from having attempted to force an unethical de-
cision upon their authors. Other journals should take notice
and refrain from the untenable practice of arbitrarily limit-
ing the number of authors of any publication.
So-called “self-plagiarism” is another issue where journal
publishers often grandstand as the custodian of highfalutin
ethics, whereas in reality they simply enforce their own fin-
ancial interests at the cost of the sacrosanct right of authors
to their own words. With the open-access movement gath-
ering momentum, many journals have stopped the dishon-
ourable practice of forcing authors to relinquish the copy-
right to their work. Yet others still insist on unfair and
nonsensical requests to hand over the copyright to pub-
lished works. It is time to expose the motives behind these
requests and clarify that, from the viewpoint of moral-
ity and scientific integrity, there is no reason why authors
should not utilise their own words as they see fit.
The limits of attribution
Much of what the SAAS writes amounts to common sense
and will be agreed upon by anybody with a firm moral
compass, but the devil lies in the detail. Consider, for ex-
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ample, the following recommendation: “A person is listed
as an author if he or she has personally made an important
scientific contribution to the planning, conduct, evaluation
or control of the research work.” This sounds entirely reas-
onable, but prospective authors may hold diverging opin-
ions on what exactly an important contribution may consist
of. Does, for example, the provision of an antibody or of a
genetically modified mouse qualify for authorship? In my
opinion, this is not necessarily so. In practice, I would ar-
gue that provision of a crucial reagent should be recognised
by a coauthorship if the reagent in question had never been
published before. Since the primary purpose of all scientif-
ic publications is to enable others to reproduce one’s find-
ings, the distribution of published reagents should be en-
tirely open and free of any attached strings – and should
definitely not be conditional on a request for authorship.
Sadly, in reality many scientists withhold all kinds of ma-
terials, or make their release dependent on unrealistic and
potentially unethical requests.
In a particularly obnoxious example of authorship running
amok, the head of a centralised facility at the University
of Zurich invoiced differential fees to the facility’s users:
those who included him as a coauthor of their papers en-
joyed a 50% rebate. Such aberrations are clearly abusive
and in my view are best combated by “naming and sham-
ing”.
Some authors are more equal than others
An issue with huge conflict potential is the order of names
in a list of authors. This is because author lists determine
the prestige of the contributors, and are often even used
to rank applicants during academic job searches. In my
laboratory, I strive to adhere to a very simple and transpar-
ent principle: the person who has made the greatest effort
to advance the project shall be named as the first author.
The person who made the second-largest effort will be the
second author, and so on. If there is disagreement, the effort
will be equated to the number of working hours spent on
the project – a parameter that is imperfect but easily meas-
urable. The principal investigator, who typically proposed
and initiated the project in question (and hopefully wrote
sizeable chunks of the paper), shall be the last author. If the
paper is the result of two or more laboratories collaborat-
ing with each other, the principal investigators of the re-
spective laboratories will occupy the second-to-last, third-
to-last, and similar positions in the author list.
The theory above seems logical and straightforward, but
again the reality can be less clear. The constraints imposed
by the order of the author list can threaten to poison the
collaborative spirit that is fundamental to any teamwork.
Coworkers may feel demotivated by being assigned a slot
deemed inferior, or they may make their cooperation con-
tingent upon unreasonable authorship requests. However,
I have found that the “equal contribution” paradigm is a
powerful instrument, which can improve fairness in the dis-
tribution of kudos while enabling optimal teambuilding.
“Equal contribution” means that two or more authors are
declared to have contributed equally to a paper and they
all should be considered “first authors”. I have been mak-
ing increasingly liberal use of this instrument, and by now
most of the papers from my laboratories sport multiple first
authors. Equal authorship is a compromise (the first slot is
still the most prized one), but I have found it to signific-
antly improve the fairness of the process, and consequently
the satisfaction of my colleagues and the productivity of
my laboratory.
It is sometimes difficult to draw a precise line between a
contribution that deserves an authorship and one that may
instead be more appropriately belong in the Acknowledg-
ments section. Here, the guidelines of the SAAS (“Activ-
ities such as measuring objects or collecting literature are
not deemed to be scientific if they are performed on the in-
structions of a third party without an appreciation of the
underlying scientific question or the need to exercise per-
sonal judgement. However, if these activities involve ana-
lysis, evaluation, interpretation or a similar intellectual
effort, or if they require special skills, they constitute sci-
entific work and may justify authorship”) are well-meant
but are too generic to offer concrete help. There is no doubt
that a laboratory technician who has conceived and ex-
ecuted a relevant experiment should be offered a full au-
thorship. But what about a postdoctoral fellow who may
have spent a few days teaching a method to an undergradu-
ate – who then applied that method to an ambitious pro-
ject? Does the introduction to a generic laboratory practice
entitle the postdoc to coauthorship on the resulting paper?
Conversely, consider the case of a laboratory rotation stu-
dent spending 3 weeks in a laboratory learning how to gen-
erate clone recombinant DNA plasmids. With some luck,
the student may generate a reagent that others will utilise
for a subsequent publication. Would that qualify for a coau-
thorship?
In my experience, these common dilemmas cannot be re-
solved with a set of generic rules. Conferment of author-
ship crucially depends on “soft” criteria, such as whether
the postdoc has been regularly devoting time to educating
younger colleagues (hence displaying a generosity that
needs to be properly rewarded), whether the method in
question was invented by that postdoc, and whether the stu-
dent has gone beyond the mere execution of a learning as-
signment, e.g. by contributing to the design of the experi-
ment. Even then, the views of those involved (the postdoc
devoting time to a younger colleague, the laboratory rota-
tion student and – last but not least – the head of the labor-
atory, who has the task of assigning the authorships) may
dramatically diverge, and the equitable resolution of such
divergences can be anything but easy.
Another interesting passage of the SAAS document reads:
“To avoid disappointments and disputes, the listing of au-
thors should be discussed by all concerned as early as pos-
sible and decisions should be recorded in writing.” Yes,
this is all true – but things can change during the course
of a project. The intended primary author may lose all en-
thusiasm for the project (and sometimes may even decide
to leave the laboratory prematurely), whereas the intended
second author can become the de facto first author. These
eventualities need to be accounted for, and they usually
cannot be predicted at the outset of a study.
Finally, the SAAS paper discusses the concept of “contrib-
utorship”, which relies on detailed descriptions of individu-
al contributions. In my view, this is a very good idea, which
has the potential to render justice and properly attribute
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the efforts of coauthors who might otherwise get lost in a
long list of individuals. Taken to its extreme, contributor-
ship may even supplant the distinction between authorship
and certain usages of the Acknowledgments section, inas-
much as it precisely enumerates each contribution and each
contributor.
The case studies described above may generate the percep-
tion that authorship management is a grim and painful exer-
cise, akin to handing down criminal sentences and slightly
less enjoyable than root canal therapy. And sometimes this
is exactly how it feels. On the other hand, the assignment of
authorships can also be an opportunity for a research labor-
atory to practice fairness, to motivate coworkers, to create
a collaborative atmosphere where the laboratory members
will understand that teamwork beats individual egoism, and
to demonstrate that hard work will be properly credited and
rewarded.
Receiving notice of acceptance of a scientific manuscript,
particularly after several rounds of tough peer-reviewing,
is always an exhilarating experience that creates joy and
bonding between all authors. The fair and transparent as-
signment of authorship helps ensuring that the day of pub-
lication will be positively remembered by all scientists in-
volved.
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